Hammons J, Warren EK, Wittling MC, Bennett FJ, et al. Tumor site influences efficacy of MEKi and immunotherapy combinations in pre-clinical model of cholangiocarcinoma. Hepatology 2025 Jul 1. doi: 10.1097/HEP.0000000000001439.
PMID: 40590857